RFA
ABBV icon

Resurgent Financial Advisors’s AbbVie ABBV Stock Holding History

Resurgent Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$858K Buy
3,946
+1,192
+43% +$264K 0.31% 78
2025
Q4 		$629K Sell
2,754
-24
-0.9% -$5.47K 0.32% 94
2025
Q3 		$643K Sell
2,778
-63
-2% -$12.8K 0.32% 92
2025
Q2 		$527K Sell
2,841
-17
-0.6% -$3.16K 0.29% 102
2025
Q1 		$599K Sell
2,858
-393
-12% -$76.4K 0.36% 77
2024
Q4 		$578K Buy
3,251
+42
+1% +$7.72K 0.34% 87
2024
Q3 		$634K Buy
3,209
+598
+23% +$112K 0.37% 79
2024
Q2 		$448K Buy
2,611
+57
+2% +$9.44K 0.28% 109
2024
Q1 		$465K Sell
2,554
-100
-4% -$17.2K 0.25% 111
2023
Q4 		$411K Sell
2,654
-454
-15% -$66.2K 0.25% 104
2023
Q3 		$463K Buy
3,108
+7
+0.2% +$1.03K 0.32% 82
2023
Q2 		$418K Buy
3,101
+147
+5% +$21.6K 0.28% 84
2023
Q1 		$471K Sell
2,954
-3,837
-57% -$587K 0.31% 83
2022
Q4 		$1.1M Sell
6,791
-512
-7% -$78.5K 0.58% 39
2022
Q3 		$980K Buy
7,303
+231
+3% +$33.1K 0.66% 42
2022
Q2 		$1.08M Buy
7,072
+454
+7% +$69.4K 0.69% 40
2022
Q1 		$1.07M Buy
6,618
+3,973
+150% +$577K 0.67% 36
2021
Q4 		$358K Buy
+2,645
New +$312K 0.29% 85

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Resurgent Financial Advisors's ABBV Position: Q1 2026 in Review

Resurgent Financial Advisors increased its AbbVie (ABBV) stake by 43% in Q1 2026, buying an estimated $264K and bringing the position to 3,946 shares worth $858K. The position accounts for 0.31% of the portfolio, ranked #78.

Resurgent Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.1M in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Resurgent Financial Advisors held 3,946 shares of AbbVie worth $858K as of Q1 2026.
  • Resurgent Financial Advisors bought 1,192 AbbVie shares in Q1 2026, an estimated $264K.
  • AbbVie made up 0.31% of Resurgent Financial Advisors's portfolio in Q1 2026, its #78 holding.
  • Resurgent Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Resurgent Financial Advisors's AbbVie position peaked at $1.1M in Q4 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.